Table 3.
Source | Category | Method | Days | Purpose | Results |
---|---|---|---|---|---|
Not given [50] | Biomedical function | Not given | 24 weeks | OA joint pain symptoms after hydrolysate ingestion for 24 weeks | OA athlete’s pain is significantly decreased |
Articular bovine chondrocytes, collagen hydrolysate source is not given [60] | Bio-synthesis and culturing | Articular cartilage chondrocytes by enzymatic hydrolysis using pronase and collagenase. Collagen hydrolysate source is not given. | 14, 28, 42 days | Culturing of hydrolysate in chondrocyte and agarose gel to enhance Type II collagen in engineered | Compressive properties, Type II collagen are improved. |
Whale shark (WS) cartilage [71] | Novel Method and Source | Enzymatic (pepsin) and acid hydrolysis. | Whale shark is not extracted before with acid and pepsin hydrolysis. | High denaturation temperature, hydroxyproline, and protein content of pepsin soluble method as compared to acid hydrolysis. | |
Chicken sternum cartilage extract [72] | Novel Source | Not given | 14 weeks | Using collagen II to reduce skin problems. | Reduction of wrinkles, inhibiting cell damage due to UV rays. |
Chicken sternum cartilage [68] | Biomedical function | Not given | 180 days | ||
Type II from bovine cartilage [70] | Novel method | Acidic hydrolysis | A novel technique and material for orthopedic problems. | Better dispersion, mechanical properties. | |
Porcine [69] | Biomedical function | Not given | 13 days | Low dosage effects of Type II on rat OA. | Less CTX-II, Better postural balance, Better motor activity. |